Loading
A phase 2/3 trial of aspirin in colorectal cancer, run by Oslo University Hospital, active but no longer recruiting.
Aspirin in Colorectal Cancer Liver Metastases is a phase 2/3, randomised interventional study registered as NCT03326791 by Oslo University Hospital, with a registry enrolment figure of 466 participants, started 2017-12-15 and due to reach its primary completion in 2022-02-01. Interventions recorded: Acetylsalicylic acid; Placebo Oral Tablet. Conditions listed: Colorectal Cancer Liver Metastases; Colorectal Cancer; Liver Metastases. Primary outcome: Disease Free Survival (DFS) after three years treatment. Sites: Denmark, Norway, Sweden. No results are recorded here; the registry entry is the source.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.